UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (33) 33
life sciences & biomedicine (32) 32
humans (27) 27
immunology (12) 12
oncology (11) 11
histocompatibility antigens class i - genetics (10) 10
animals (9) 9
cytotoxicity (9) 9
histocompatibility antigens class i - immunology (9) 9
female (8) 8
gene expression (8) 8
killer cells, natural - immunology (8) 8
major histocompatibility complex (8) 8
cell biology (7) 7
flow cytometry (7) 7
genetic aspects (7) 7
ligands (7) 7
male (7) 7
alleles (6) 6
cell line, tumor (6) 6
histocompatibility antigens class i - metabolism (6) 6
immunotherapy (6) 6
adult (5) 5
biochemistry & molecular biology (5) 5
cancer (5) 5
health aspects (5) 5
mhc class i-related chain a (5) 5
middle aged (5) 5
proteins (5) 5
research (5) 5
studies (5) 5
aged (4) 4
care and treatment (4) 4
cytotoxicity, immunologic - immunology (4) 4
development and progression (4) 4
gene expression regulation, neoplastic - drug effects (4) 4
hepatocellular carcinoma (4) 4
hepatoma (4) 4
histocompatibility antigens class i - biosynthesis (4) 4
killer cells, natural - metabolism (4) 4
lymphocytes (4) 4
major histocompatibility complex class i-related chain a (4) 4
mhc class i-related chain molecule (4) 4
natural killer cells (4) 4
nk cell lectin-like receptor subfamily k - metabolism (4) 4
nkg2d (4) 4
osteosarcoma (4) 4
pathology (4) 4
stomatognathic diseases (4) 4
transcription factors (4) 4
tumor escape - immunology (4) 4
tumors (4) 4
valproic acid (4) 4
antibodies (3) 3
chemotherapy (3) 3
gene expression regulation, neoplastic (3) 3
genes (3) 3
genetic predisposition to disease (3) 3
genetics & heredity (3) 3
genotype (3) 3
hematology (3) 3
histocompatibility antigens class i - blood (3) 3
interferon (3) 3
membrane proteins - genetics (3) 3
metastasis (3) 3
mhc class i-related chain (3) 3
mhc class i‐related chain a (3) 3
mica (3) 3
mice (3) 3
nk cells (3) 3
nkg2d receptor (3) 3
odds ratio (3) 3
original (3) 3
polymorphism, single nucleotide (3) 3
promoter regions, genetic (3) 3
risk factors (3) 3
surveillance (3) 3
t cells (3) 3
valproic acid - pharmacology (3) 3
adolescent (2) 2
amino acid sequence (2) 2
analysis (2) 2
antigen presentation (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - pharmacology (2) 2
apoptosis (2) 2
biophysics (2) 2
biotechnology & applied microbiology (2) 2
bone cancer (2) 2
cancer therapies (2) 2
carcinoma, hepatocellular - genetics (2) 2
carcinoma, hepatocellular - pathology (2) 2
case-control studies (2) 2
cd4-positive t-lymphocytes - immunology (2) 2
cd8 coreceptor (2) 2
cd8-positive t-lymphocytes - immunology (2) 2
cell line (2) 2
cell proliferation (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
FEBS letters, ISSN 0014-5793, 04/2007, Volume 581, Issue 7, pp. 1317 - 1322
.... This inhibition was associated with decreased expression and function of NK cell activating receptors NKp46 and NKp30 as well as impaired granule exocytosis. NFκ... 
Cytotoxicity | NK cells | Histone deacetylase inhibitors | NK cell activating and inhibitory receptors | Nuclear factor kappa B | threshold cycles | interleukin-2 | lymphocyte function antigen-1 | VPA | suberoylanilide hydroxamic acid | MHC class I-related chain A/B | NK group 2, member D | IMDM | natural killer | NKG2D | DNAX accessory molecule-1 | NKG2A | relative fluorescent units | fetal calf serum | HDACi | Iscove's modified Dulbecco's medium | histone deacetylase inhibitors | RFU | SAHA | LFA-1 | MICA/B | NFκB | DNAM-1 | IL-2 | valproic acid | natural cytotoxic receptors | mAb | NK group 2, member A | phycoerythrin | killer immunoglobulin-like receptors | KIR | C T | FCS | monoclonal antibody | NCR | Biochemistry & Molecular Biology | Biophysics | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Cell Line | NF-kappa B - antagonists & inhibitors | Natural Cytotoxicity Triggering Receptor 1 | Natural Cytotoxicity Triggering Receptor 3 | Humans | Enzyme Inhibitors - pharmacology | Valproic Acid - pharmacology | Receptors, Immunologic - antagonists & inhibitors | Killer Cells, Natural - enzymology | Lymphocyte Activation - drug effects | Interleukin-2 - pharmacology | Killer Cells, Natural - immunology | Histone Deacetylase Inhibitors | Killer Cells, Natural - drug effects | Receptors, Immunologic - immunology | Cytotoxicity, Immunologic - drug effects | Hydroxamic Acids - pharmacology | Index Medicus
Journal Article
Oncoimmunology, ISSN 2162-402X, 04/2015, Volume 4, Issue 7, pp. e1016700 - 14
It has become evident that tumor-induced immuno-suppressive factors in the tumor microenvironment play a major role in suppressing normal functions of effector... 
HLA, human leukocyte antigen | TCR, T-cell receptor | RCC, renal cell carcinoma | iNOS, inducible nitric-oxide synthase | GM-CSF, granulocyte macrophage colony-stimulating factor | MICA, MHC class I related molecule A | PGE2, prostaglandin E2 | TGF-β, transforming growth factor β | immunosuppression | MHC, major histocompatibility | TRAIL, TNF-related apoptosis-inducing ligand | T cells | RCAS1, receptor-binding cancer antigen expressed on Siso cells 1 | XIAP, X-linked inhibitor of apoptosis protein | NO, nitric oxide | PD-1, program death receptor-1 | immunotherapy | MICB, MHC class I related molecule B | MDSC, myeloid-derived suppressor cells | IMC, immature myeloid cell | PARP, poly ADP-ribose polymerase | IDO, indoleamine-2,3- dioxygenase | STAT3, signal transducer and activator of transcription 3 | VCAM-1, vascular cell adhesion molecule-1 | IL-10, interleukin-10 | GPI, glycosylphosphatidylinositol | 1MT, 1-methyltryptophan | Gal1, galectin-1 | immunosuppressive factors | PD-L1, programmed death ligand 1 | HDACi, histone deacetylase inhibitor | SOCS, suppressor of cytokine signaling | COX2, cyclooxygenase-2 | tumor microenvironment | SVV, survivin | Immunosuppression | Immunosuppressive factors | Tumor microenvironment | Immunotherapy | Oncology | Immunology | Life Sciences & Biomedicine | Science & Technology
Journal Article
Journal Article
Journal Article
Journal Article
Clinical and experimental immunology, ISSN 1365-2249, 02/2019, Volume 196, Issue 3, pp. 336 - 344
Journal Article